Particularly, subtype-specific agonists and antagonists help to further understand the complex role of S1P signaling, and it seems promising to further elucidate these roles, especially the role of S1PR2 and S1PR3 in inflammatory skin diseases and itch. This evidence concerns the gene MBTPS1 and inflammatory skin disease.